Get the Stockscreener App
15.01
9.20%
-1.52
After Hours:
14.85
-0.16
-1.07%
Caredx Inc stock is traded at $15.01, with a volume of 1.55M.
It is down -9.20% in the last 24 hours and up +0.33% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$16.53
Open:
$16.46
24h Volume:
1.55M
Relative Volume:
1.14
Market Cap:
$798.94M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-5.5799
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
+3.73%
1M Performance:
+0.33%
6M Performance:
+5.85%
1Y Performance:
-35.33%
1-Day Range:
$14.58
$16.46
1-Week Range:
$14.27
$16.60
52-Week Range:
$10.96
$26.37
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
15.01 | 850.18M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
565.98 | 213.27B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
210.67 | 149.89B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.74 | 57.51B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.49 | 41.61B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.86 | 35.78B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
What is the fair value estimate for CareDx Inc (1K9) stock in 2025Market Movement Recap & Low Risk Investment Opportunities - newser.com
CareDx, Inc. Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - MarketScreener
Trend analysis for CareDx Inc this weekCEO Change & Weekly Momentum Picks - newser.com
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript - Insider Monkey
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Markets Financial Content
BTIG Maintains CareDx (CDNA) Buy Recommendation - Nasdaq
3 Analysts Have This To Say About CareDx - Benzinga
CDNA: BTIG Raises Price Target to $25, Maintains Buy Rating | CD - GuruFocus
Is CareDx Inc stock trading near support levelsPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com
Is CareDx Inc stock a top momentum playQuarterly Trade Review & Stepwise Trade Execution Plans - fcp.pa.gov.br
Will CareDx Inc stock maintain dividend yieldQuarterly Profit Report & Free Real-Time Market Sentiment Alerts - fcp.pa.gov.br
Will CareDx Inc stock outperform international peers2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
CareDx (CDNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - sharewise.com
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates - sharewise.com
What Fibonacci levels say about CareDx Inc rebound2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
CareDx (CDNA) Turns Profitable on $89.4M One-Off Gain, Challenging Quality of Earnings Narrative - Yahoo Finance
CareDx Inc. Reports Strong Q3 Earnings Growth - TipRanks
CareDx (NASDAQ:CDNA) Releases Quarterly Earnings Results - MarketBeat
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution By Investing.com - Investing.com South Africa
Caredx Inc earnings beat by $0.36, revenue topped estimates - Investing.com Australia
CareDx Q3 2025 presentation slides: Revenue up 21%, guidance raised despite market caution - Investing.com Australia
Why CareDx Inc stock is trending among retail tradersTrend Reversal & Weekly High Return Stock Forecasts - fcp.pa.gov.br
Applying sector rotation models to CareDx IncChart Signals & Entry Point Confirmation Alerts - newser.com
CareDx: Q3 Earnings Snapshot - CT Insider
CareDx Inc (CDNA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance By GuruFocus - Investing.com Canada
Detecting price anomalies in CareDx Inc with AIVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
CareDx Reports Strong Q3 2025 Financial Results - TipRanks
CareDx Outpaces Expectations And Raises Its 2025 Outlook - Finimize
Earnings call transcript: CareDx Q3 2025 revenue beats forecast, stock dips By Investing.com - Investing.com South Africa
Transcript : CareDx, Inc, Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener
Earnings call transcript: CareDx Q3 2025 revenue beats forecast, stock dips - Investing.com
CareDx Inc (CDNA) Q3 2025 Earnings: EPS of $0.03 Beats Estimate, - GuruFocus
Transplant diagnostics firm CareDx Q3 revenue beats estimates, helped by new product launches - MarketScreener
CareDx Reports Strong Q3 Financial Results - TipRanks
CareDx Announces Third Quarter 2025 Financial Results - The Joplin Globe
Why CareDx Inc (1K9) stock remains stable2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Can you recover from losses in CareDx IncTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):